News and Insights
SpectrumX Secures MHRA Licence for Medicinal Specials, Marking a Significant Milestone in Healthcare Innovation
SpectrumX proudly announces the acquisition of its licence, to manufacture...
Read More
SpectrumX to showcase its groundbreaking, HOCl-based biocidal product Spectricept Care+ at IP2023
16 October 2023 Liverpool – SpectrumX (“the Company”), a...
Read More
SpectrumX demonstrates sustainability credentials with ISO 14001 certification
London – SpectrumX, a UK-based healthcare and pharmaceutical company,...
Read More
SpectrumX appoints formulation chemist to lead product design and development of new cosmetics line
London – SpectrumX, a UK-based healthcare and pharmaceutical company,...
Read More
SpectrumX to provide full-service infection prevention solution to healthcare facilities
Damien Hancox, CEO, announces partnerships with industry-leading healthcare specialists Ophardt...
Read More
SpectrumX Expands into UK’s South East Region
Industry expert, Samantha Gibbons, appointed to newly created post of...
Read More
SpectrumX Expands into North East of England and Scotland
London – SpectrumX, a UK-based healthcare and pharmaceutical company, today...
Read More
SpectrumX adds financial controller to management team
Damien Hancox, CEO, describes hire of life sciences sector finance...
Read More
SpectrumX confirms next step in clinical development of respiratory drug candidate SPX-001 after MHRA meeting
CEO Damien Hancox outlines next step after constructive scientific advice...
Read More
SpectrumX announces appointment of new regional account manager, UK South West
London – SpectrumX, a UK-based healthcare and pharmaceutical company, today...
Read More
